Fig. 1. Proteostasis governs the life of a protein from synthesis to degradation.
Shown is a simplified diagram of key steps in the life of a protein and how this is guided by the proteostasis network (in green). Management of protein folding is normally regulated by a network of about 800 proteins in humans. When proteostasis fails, proteins can misassemble into aggregates (red). The failure of proteostasis correlates with a gain of proteotoxicity; some of the postulated mechanisms covered in this review are indicated.
in the case of being irreparably misfolded, targeted for degradation by the ubiquitin proteasome system (UPS) or autophagy. Hsp70 family proteins are also important in preventing misfolding of nascent chains during translation and ensuring optimum translation rates. Elements of the PN also play critical roles targeting and translocating proteins to cellular organelles including the nucleus, mitochondria and the endoplasmic reticulum (ER), which contain their own subnetworks of quality control machinery and checkpoints for folding.
Failure of Proteostasis and Protein Aggregation
Unfolded states are permissive to entering misfolding pathways that result in aggregation, which provides a rival low energy state to the native fold (3) . For this reason, aggregation is often observed as symptomatic of problems in maintaining proteostasis (1) . For example, proteins accumulate into punctate aggregate structures inside neurons, known as inclusions, as a hallmark of neurodegenerative diseases including Alzheimer's disease, ALS and Huntington's disease (1) . Proteins may also naturally aggregate during the normal ageing process, with the PN remodeling to accommodate the changes -a process that may be dysregulated in neurodegenerative disease (4) . Mutations can also change the folding stability of individual proteins, which may modify baseline proteostasis capacity and influence disease risk (5) . One of the great challenges of current research efforts is in understanding how protein aggregation relates to toxicity. One of the longest standing theorems is that soluble protein oligomers, as precursors to a larger amyloid state, are directly proteotoxic and that this seems to be independent of the protein sequence (6) . However, the mechanisms for toxicity, and the relevance to disease remain to be robustly validated (6) . Possible routes of toxicity include physical disruption of membranes or other cellular structures, or interference with synaptic structure and plasticity (7) . Larger aggregates seem to be less toxic, and this may arise from a lower concentration of effective reactive 'ends' of fibrils or cellular mechanisms to sequester the dispersed oligomers together (8, 9) . One of the more interesting recent hypotheses for proteotoxicity of protein aggregates arises from the observation that markers of stress granule abnormalities appear in pathology (notably ALS) (10) . Indeed several RNA granule proteins, most notably trans-activation element (TAR) DNA binding protein-43 (TDP-43), FUS and hnRNP family proteins cause ALS when mutated. Stress granules, and related structures, P-bodies ( Fig. 1) , are condensed foci of mRNA and ribonucleoproteins that form under translational stresses (10) . They act as sites for temporal translational repression and quality control of mRNAribonucleoprotein. Recent studies have suggested many RNA granule proteins contain predicted prion-like domains that mediate liquid:liquid protein phase separation and/ or 'functional' amyloid scaffolding (11) . The presence of 'functional amyloid' indicates a necessity for these structures to be rigorously tamed to avoid pathological aggregation into amyloid fibrils. Indeed, mutations or conditions that tip the balance to pathological aggregation have been proposed as a basis for these neurodegenerative diseases (12) .
Mechanisms of Misfolded Protein SequestrationCell Driven Inclusion Formation
While protein oligomers or nascent proteins may themselves be toxic, there is also evidence that cells actively cluster together misfolded proteins for sequestration. The most compelling evidence for this model is from a key study showing that in cells expressing mutant Huntingtin exon 1, cells that formed inclusions had greater rates of survival than cells than cells that did not (13) . The mechanisms for this effect with Huntingtin exon 1 remain to be determined, however, similar 'active' mechanisms of inclusion building have been proposed with other misfolded proteins. The original model was that of the 'aggresome', which described a dynein-mediated retrograde transport mechanism of misfolded DF508 Cystic Fibrosis Transmembrane conductance regulator protein into the microtubule organising centre (14) . The aggresome model however, is problematic in that it does not appropriately define the diversity of processes that sequester aggregating proteins into a centralsed location. Recent studies have partly addressed this deficiency by unearthing two distinct aggresome-like compartments for aggregating proteins. One is the juxtanuclear quality control (JUNQ), which comprises reversibly-aggregated proteins and the other is the insoluble protein deposit (IPOD), which comprises irreversibly-aggregated proteins ( Fig. 1) (9) . Different disease-associated aggregating proteins seem to preferentially partition into either JUNQ or IPOD exclusively, and that these compartments may correlate with different mechanisms of aggregation (15) . Huntingtin exon 1 accumulates in IPOD-like structures. By contrast, polyalanine, which aggregates via soluble a-helical clusters, and SOD1 mutants, which also cluster into soluble oligomers prior to aggregation, accumulate in JUNQ-like structures (16) . FUS and TDP-43 partitioned into both structures and another unidentified structure (17) . These data indicate that aggregation into foci arises via diverse processes, which are in part consistent with the JUNQ and IPOD models, but which also seem to involve a further uncharacterised layer of complexity. Hence, critical questions remain as to what factors drive proteins to different compartments, how the elements of different models fit together, how the additional inclusion types relate to the JUNQ and IPOD structures, and whether there are further inclusion types that remain to be discovered.
An 'Omics View of Proteostasis
'Omics technologies have begun to transform our understanding of what happens to the proteome under proteostasis stress. Of note is a recent study showing that the nuclear pore is fundamentally damaged in cells that display extensive cytoplasmic aggregates of unrelated, aggregation-prone proteins (18) . Components of the import and/or export machinery coaggregate with diseaseassociated mutant proteins, including polyglutaminecontaining huntingtin protein, mutant TDP-43 and the C9orf72-associated polydipeptides (18) . Indeed, the progressive loss of proteostasis may account for the observation of nuclear transport becoming increasingly 'leaky' with ageing (19) .
'Omics, along with computational approaches, has also
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enabled insight to which proteins in the proteome become more vulnerable to aggregation under proteostasis stress. Indeed in different organisms and cell culture conditions, hundreds of proteins aggregate under stress (20, 21) . More importantly, distinct stress types tend to induce the same proteins to aggregate by reducing their aggregation threshold, indicating the presence of a metastable sub-proteome (22) . This includes many regulators of proteostasis, such as chaperones, and proteasome subunits (23) . Others have shown that in C. elegans, highly abundant proteins become supersaturated with respect to their solubility and most extensively contribute to aggregate loads during ageing, despite their otherwise low propensity to aggregate (24) . A supersaturation score, which combines experimental and bioinformatics data, has been used to explain which proteins coaggregate with amyloid plaques, neurofibrillary tangles, Lewy bodies and artificial b-proteins, as well as proteins that aggregate in C. elegans during ageing (25) .
While many proteins are likely to be aggregating 'inappropriately' under stress, there is also evidence for an adaptive aggregation response as well. For example, under heat stress, many proteins form transiently aggregated complexes that remain functionally competent, and these are not degraded upon recovery (20) . Such structures were suggested to aid in the management of the stressed proteome (20) .
Quantification of Proteostasis
A major area of development in the study of proteostasis involves building quantitative tools to mechanistically probe the PN. One approach to do this relies on metastable reporter proteins that engage with the PN and read out the effectiveness of suppressing aggregation as an indicator of proteostasis efficacy. This includes temperature-sensitive endogenous proteins, which have been used to identify novel regulators of the PN in C. elegans (26) and to probe the collapse of proteostasis when disease-associated proteins are expressed. More advanced strategies involved designer ectopic reporters including destabilised mutants of firefly luciferase, which is a known chaperone substrate that requires Hsp70 and Hsp90 to fold (27) , and the de novo designed enzyme retroaldolase as a sensor of proteome stress (28) . These reporters offer the advantage of not interfering with normal biological pathways and have been used in the studies cited above to probe changes in proteostasis induced by drugs, disease proteins, and ageing.
Another strategy for gaining insight into proteostasis has been the systems approach of computationally modelling the entire PN. This strategy offers mechanistic insight into the connections between different modules of the PN in a way that makes it possible to make sense of experimental data and make predictions that informatively guide experiments. FoldEco provides a comprehensive computational model of the PN in Escherichia coli (29) . This platform provides the capacity to model, and make predictions about, the kinetics of chaperone-protein interactions as well as synthesis, aggregation and degradation, in a fully integrated system. It can also be 'fitted' to experimental data for a mechanistic understanding of proteostasis (30) . However, transferring this approach to eukaryotic cells remains an ongoing challenge because of a vastly more complicated proteostasis networks.
The Path Ahead
The true potential of proteostasis measurement will be realised when computational models can be integrated with powerful tools for measuring proteostasis activity. Further work, which our lab is actively engaged in, will be required to develop extremely well-characterised sensors that are able probe the diverse arms of the proteostasis network without disrupting it, and yield quantitative information that can feed into network models that enable information-rich analysis.
In conclusion, research into mechanisms of proteostasis and their relationship to protein aggregation in disease has progressed substantially in the last few years. We see several key questions as immediate challenges to be addressed. An important question is how generalisable are the mechanisms of toxicity caused by aggregation of different proteins? Are the mechanisms of proteotoxicity non-specific? And are there certain machinery hotspots, such as the nuclear pore, that need to be 'hit' to trigger disease? Another gap is defining precisely which proteins aggregate in the proteome under proteostasis collapse and probing whether this explains the changes seen in disease. Given that TDP-43 mislocalisation is observed as marker of all forms of sporadic ALS, is TDP-43 simply a bellwether for a broader subproteome highly prone to aggregation under stress? A large part of our focus is on building new tools and approaches that can get at such problems including more quantitative measures of proteostasis.
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